2021
DOI: 10.1016/j.bioorg.2021.105129
|View full text |Cite
|
Sign up to set email alerts
|

Cyanobiphenyls: Novel H3 receptor ligands with cholinesterase and MAO B inhibitory activity as multitarget compounds for potential treatment of Alzheimer’s disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
9
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

1
4

Authors

Journals

citations
Cited by 12 publications
(9 citation statements)
references
References 56 publications
0
9
0
Order By: Relevance
“…The synthesis of the desired final compounds 1−16 was achieved through the synthetic route presented in Scheme 1. According to the previously described procedure, 19,21,22,24,25 the phenoxy alkyl bromides a−i were obtained mainly by one-step alkylation of commercially available phenols with 1,3-dibromopropane (a−e), 1,4dibromobutane (f, i), 1,5-dibromopentane (g), or 1,6dibromohexane (h) in propan-1-ol under reflux conditions. Obtained precursor bromides were then coupled with 3methylpiperidine (1), 4-methylpiperidine (2), azepane (3), pyrrolidine (4), piperidine (5−11), 4-(piperidin-4-yl)pyridine (12−15), or 2-(piperazin-1-yl)pyrazine (16) in a mixture of ethanol/water with powdered potassium carbonate and a catalytic amount of potassium iodide.…”
Section: Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…The synthesis of the desired final compounds 1−16 was achieved through the synthetic route presented in Scheme 1. According to the previously described procedure, 19,21,22,24,25 the phenoxy alkyl bromides a−i were obtained mainly by one-step alkylation of commercially available phenols with 1,3-dibromopropane (a−e), 1,4dibromobutane (f, i), 1,5-dibromopentane (g), or 1,6dibromohexane (h) in propan-1-ol under reflux conditions. Obtained precursor bromides were then coupled with 3methylpiperidine (1), 4-methylpiperidine (2), azepane (3), pyrrolidine (4), piperidine (5−11), 4-(piperidin-4-yl)pyridine (12−15), or 2-(piperazin-1-yl)pyrazine (16) in a mixture of ethanol/water with powdered potassium carbonate and a catalytic amount of potassium iodide.…”
Section: Resultsmentioning
confidence: 99%
“… a Data published in ref . b Recalculated from data published in ref . c Data published in ref . d Data published in ref . e Data published in ref . f Given data represent mean values within the 95% confidence interval (CI). …”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations